Literature DB >> 10735903

Longitudinal study of adaptation to the stress of bone marrow transplantation.

B L Fife1, G A Huster, K G Cornetta, V N Kennedy, L P Akard, E R Broun.   

Abstract

PURPOSE: This prospective longitudinal study of adaptation to bone marrow transplantation (BMT) addressed three questions: (1) When during BMT do individuals experience the greatest distress? (2) What factors are associated with this distress? (3) Are there variables that could be potential clinical indicators of persons in greatest need of preventive intervention? PATIENTS AND METHODS: One hundred one participants undergoing either an autologous or allogeneic BMT completed questionnaires before hospitalization, before bone marrow infusion, 7 days and 14 days after transplantation, and then 1 month, 3 months, and 12 months after hospitalization. Adaptation was indicated by the degree of emotional distress. Independent variables were personal control, social support from specific sources, cognitive response, self-perception, and coping strategies, controlling for symptomatology.
RESULTS: The greatest emotional distress occurred after admission to the hospital and before the bone marrow infusion. Anxiety and depression decreased 1 week after the transplant, although symptomatology increased during this time. The periods of least emotional distress were 3 months and 1 year after transplantation. Factors that accounted for the greatest variance in emotional distress/adaptation were the degree of emotional distress at baseline, personal control, cognitive response, and symptomatology.
CONCLUSION: According to this longitudinal study, which includes pretransplant data, data from in-hospital transplantation, and posttransplant data, (1) psychosocial vulnerability of these BMT recipients was greatest during hospitalization before the transplant, (2) perceived personal control may be a potential indicator of vulnerability to secondary psychosocial morbidity, and (3) the demonstrated significance of psychosocial well-being before BMT indicates the importance of obtaining prospective data for both research and clinical purposes.

Entities:  

Mesh:

Year:  2000        PMID: 10735903     DOI: 10.1200/JCO.2000.18.7.1539

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  38 in total

1.  Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS).

Authors:  Can-Lan Sun; Liton Francisco; K Scott Baker; Daniel J Weisdorf; Stephen J Forman; Smita Bhatia
Journal:  Blood       Date:  2011-08-05       Impact factor: 22.113

2.  Coping strategies modify risk of depression associated with hematopoietic cell transplant symptomatology.

Authors:  Anna Barata; Brian D Gonzalez; Steven K Sutton; Brent J Small; Paul B Jacobsen; Teresa Field; Hugo Fernandez; Heather Sl Jim
Journal:  J Health Psychol       Date:  2016-04-22

3.  Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.

Authors:  Areej El-Jawahri; Yi-Bin Chen; Ruta Brazauskas; Naya He; Stephanie J Lee; Jennifer M Knight; Navneet Majhail; David Buchbinder; Raquel M Schears; Baldeep M Wirk; William A Wood; Ibrahim Ahmed; Mahmoud Aljurf; Jeff Szer; Sara M Beattie; Minoo Battiwalla; Christopher Dandoy; Miguel-Angel Diaz; Anita D'Souza; Cesar O Freytes; James Gajewski; Usama Gergis; Shahrukh K Hashmi; Ann Jakubowski; Rammurti T Kamble; Tamila Kindwall-Keller; Hilard M Lazarus; Adriana K Malone; David I Marks; Kenneth Meehan; Bipin N Savani; Richard F Olsson; David Rizzieri; Amir Steinberg; Dawn Speckhart; David Szwajcer; Helene Schoemans; Sachiko Seo; Celalettin Ustun; Yoshiko Atsuta; Jignesh Dalal; Carmem Sales-Bonfim; Nandita Khera; Theresa Hahn; Wael Saber
Journal:  Cancer       Date:  2017-01-19       Impact factor: 6.860

4.  Disrupted sleep in breast and prostate cancer patients undergoing radiation therapy: the role of coping processes.

Authors:  Kamala S Thomas; Julienne Bower; Michael A Hoyt; Saviz Sepah
Journal:  Psychooncology       Date:  2010-07       Impact factor: 3.894

5.  Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.

Authors:  Areej El-Jawahri; Thomas LeBlanc; Harry VanDusen; Lara Traeger; Joseph A Greer; William F Pirl; Vicki A Jackson; Jason Telles; Alison Rhodes; Thomas R Spitzer; Steven McAfee; Yi-Bin A Chen; Stephanie S Lee; Jennifer S Temel
Journal:  JAMA       Date:  2016-11-22       Impact factor: 56.272

6.  Posttraumatic stress symptoms predict impaired neutrophil recovery in stem cell transplant recipients.

Authors:  Stevan E Hobfoll; James I Gerhart; Alyson K Zalta; Kurrie Wells; John Maciejewski; Henry Fung
Journal:  Psychooncology       Date:  2015-01-27       Impact factor: 3.894

7.  Active Coping and Perceived Social Support Mediate the Relationship Between Physical Health and Resilience in Liver Transplant Candidates.

Authors:  Amelia Swanson; Jessica Geller; Kelly DeMartini; Anne Fernandez; Dwain Fehon
Journal:  J Clin Psychol Med Settings       Date:  2018-12

8.  What do transplant physicians think about palliative care? A national survey study.

Authors:  Areej El-Jawahri; Thomas W LeBlanc; Linda J Burns; Ellen Denzen; Christa Meyer; Lih-Wen Mau; Eric J Roeland; William A Wood; Effie Petersdorf
Journal:  Cancer       Date:  2018-10-05       Impact factor: 6.860

9.  Is physical exercise possible in patients with critical cytopenia undergoing intensive chemotherapy for acute leukaemia or aggressive lymphoma?

Authors:  Thomas Elter; Martina Stipanov; Eva Heuser; Michael von Bergwelt-Baildon; Wilhelm Bloch; Michael Hallek; Freerk Baumann
Journal:  Int J Hematol       Date:  2009-07-24       Impact factor: 2.490

10.  The effect of pre-transplant distress on immune reconstitution among adult autologous hematopoietic cell transplantation patients.

Authors:  Bonnie A McGregor; Karen L Syrjala; Emily D Dolan; Shelby L Langer; Mary Redman
Journal:  Brain Behav Immun       Date:  2012-08-13       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.